EA200000933A1 - Пептидные композиции и препараты и их применение - Google Patents
Пептидные композиции и препараты и их применениеInfo
- Publication number
- EA200000933A1 EA200000933A1 EA200000933A EA200000933A EA200000933A1 EA 200000933 A1 EA200000933 A1 EA 200000933A1 EA 200000933 A EA200000933 A EA 200000933A EA 200000933 A EA200000933 A EA 200000933A EA 200000933 A1 EA200000933 A1 EA 200000933A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- peptides
- directed
- specifically
- preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
Abstract
Настоящее изобретение направлено на композицию, которая применяется для повышения мягкости, эластичности или улучшения внешнего вида ткани. Конкретно, настоящее изобретение направлено на композицию, приготавливаемую из пептидов, которые в существенной степени соответствуют тем пептидам, которые образуются в результате термического расщепления эластина. Такой препарат предпочтительно применяют на кожу человека в качестве косметической или лечебной композиции. Конкретно заявляемая композиция содержит известную химическую модификацию описываемых здесь пептидов, а именно модификацию по C- и N-концам, включая добавление аминокислот к любому из концов пептидных фрагментов.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/039,308 US6069129A (en) | 1998-03-13 | 1998-03-13 | Elastin derived composition and method of using same |
PCT/US1999/005496 WO1999045941A1 (en) | 1998-03-13 | 1999-03-12 | Peptide compositions and formulations and use of same |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200000933A1 true EA200000933A1 (ru) | 2001-04-23 |
EA003857B1 EA003857B1 (ru) | 2003-10-30 |
Family
ID=21904781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000933A EA003857B1 (ru) | 1998-03-13 | 1999-03-12 | Пептидная фармацевтическая композиция и способ повышения эластичности ткани |
Country Status (19)
Country | Link |
---|---|
US (2) | US6069129A (ru) |
EP (1) | EP1064010B1 (ru) |
JP (1) | JP2002506041A (ru) |
KR (1) | KR100612535B1 (ru) |
CN (1) | CN100364606C (ru) |
AP (1) | AP2000001905A0 (ru) |
AT (1) | ATE386536T1 (ru) |
AU (1) | AU765379B2 (ru) |
BR (1) | BR9908749A (ru) |
CA (1) | CA2322839A1 (ru) |
DE (1) | DE69938174T2 (ru) |
EA (1) | EA003857B1 (ru) |
HK (1) | HK1036225A1 (ru) |
ID (1) | ID28270A (ru) |
IL (2) | IL138453A0 (ru) |
NO (1) | NO325371B1 (ru) |
NZ (1) | NZ506898A (ru) |
OA (1) | OA11531A (ru) |
WO (1) | WO1999045941A1 (ru) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6809075B1 (en) * | 2000-05-30 | 2004-10-26 | Connective Tissue Imagineering Llc | Elastin peptide analogs and uses of same incombination with skin enhancing agents |
US6962904B1 (en) * | 1998-03-13 | 2005-11-08 | Connective Tissue Imagineering | Elastin peptide analogs and uses thereof |
US6777389B1 (en) * | 1998-11-19 | 2004-08-17 | Connective Tissue Imagineering Llc | Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides |
US6903244B1 (en) | 1999-02-26 | 2005-06-07 | University Of Utah Research Foundation | Mice which are +/− or −/− for the elastin gene as models for vascular disease |
EP1300418A1 (en) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
US6794362B1 (en) * | 2000-05-30 | 2004-09-21 | Connective Tissue Imagineering Llc | Asparagine containing elastin peptide analogs |
NZ523403A (en) * | 2000-05-30 | 2005-04-29 | Connective Tissue Imagineering | Compounds that increase tissue elasticity and turgor which are analogous to portions of elastin |
SG98420A1 (en) * | 2000-07-13 | 2003-09-19 | Purzer Pharmaceutical Co Ltd | Method for transferring one or more active ingredients between different phase carriers |
US6608026B1 (en) * | 2000-08-23 | 2003-08-19 | Board Of Regents, The University Of Texas System | Apoptotic compounds |
US20030198631A1 (en) * | 2002-04-18 | 2003-10-23 | Healthpoint, Ltd. | Thermolysin enzymatic wound debrider |
US7560430B2 (en) | 2003-02-14 | 2009-07-14 | Human Matrix Sciences, Llc | Elastin digest compositions and methods utilizing same |
FR2854897B1 (fr) * | 2003-05-12 | 2007-05-04 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane. |
US6927206B2 (en) * | 2003-06-06 | 2005-08-09 | Procyte Corporation | Compositions and methods for treatment of rosacea |
GB0313644D0 (en) * | 2003-06-12 | 2003-07-16 | Univ Bristol | Inhibition of infection |
US20050063932A1 (en) * | 2003-08-14 | 2005-03-24 | Natalie Dilallo | Skin care compositions including hexapeptide complexes and methods of their manufacture |
US20060198800A1 (en) * | 2003-08-14 | 2006-09-07 | Natalie Dilallo | Skin care compositions including hexapeptide complexes and methods of their manufacture |
US7803522B2 (en) * | 2004-02-13 | 2010-09-28 | Human Matrix Sciences, Llc | Elastin producing fibroblast formulations and methods of using the same |
US7666829B2 (en) * | 2004-02-20 | 2010-02-23 | Human Matrix Sciences, Llc | Compositions for elastogenesis and connective tissue treatment |
US7392611B2 (en) * | 2004-12-22 | 2008-07-01 | Smith & Wesson Corp. | Apparatus and method for firearm takedown |
US8114829B2 (en) * | 2005-02-22 | 2012-02-14 | Human Matrix Sciences, Llc | Elastin protective polyphenolics and methods of using the same |
US8642578B2 (en) | 2005-03-29 | 2014-02-04 | Human Matrix Sciences, Llc | Elastin protective polyphenolics and methods of using the same |
WO2006125049A2 (en) | 2005-05-17 | 2006-11-23 | Human Matrix Sciences, Llc | Elastin producing fibroblasts |
JP2007045722A (ja) * | 2005-08-08 | 2007-02-22 | Kyushu Institute Of Technology | 水溶性エラスチンとそれを含む食品及び医薬 |
EP2040732A4 (en) | 2006-05-15 | 2009-08-19 | Valio Ltd | NEW USE OF THERAPEUTICALLY USEFUL PEPTIDES |
US8778376B2 (en) | 2006-06-09 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating |
JP5276813B2 (ja) * | 2006-08-25 | 2013-08-28 | 日本ハム株式会社 | エラスチン分解ペプチド並びにエラスチン及びその酵素分解ペプチドの製造方法 |
US8828354B2 (en) * | 2008-03-27 | 2014-09-09 | Warsaw Orthopedic, Inc. | Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
US20090264478A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Sulfasalazine formulations in a biodegradable polymer carrier |
US8557273B2 (en) * | 2008-04-18 | 2013-10-15 | Medtronic, Inc. | Medical devices and methods including polymers having biologically active agents therein |
US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
US20090264489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation |
US8956641B2 (en) | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
US8883768B2 (en) * | 2008-04-18 | 2014-11-11 | Warsaw Orthopedic, Inc. | Fluocinolone implants to protect against undesirable bone and cartilage destruction |
US9125917B2 (en) * | 2008-04-18 | 2015-09-08 | Warsaw Orthopedic, Inc. | Fluocinolone formulations in a biodegradable polymer carrier |
US9072727B2 (en) | 2008-04-18 | 2015-07-07 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
US9289409B2 (en) * | 2008-04-18 | 2016-03-22 | Warsaw Orthopedic, Inc. | Sulindac formulations in a biodegradable material |
US8956636B2 (en) | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Methods and compositions for treating postoperative pain comprosing ketorolac |
US20090263451A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain |
US9132119B2 (en) | 2008-04-18 | 2015-09-15 | Medtronic, Inc. | Clonidine formulation in a polyorthoester carrier |
US8629172B2 (en) | 2008-04-18 | 2014-01-14 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising clonidine |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US8846068B2 (en) | 2008-04-18 | 2014-09-30 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising a local anesthetic |
US9132085B2 (en) * | 2008-04-18 | 2015-09-15 | Warsaw Orthopedic, Inc. | Compositions and methods for treating post-operative pain using clonidine and bupivacaine |
US8722079B2 (en) | 2008-04-18 | 2014-05-13 | Warsaw Orthopedic, Inc. | Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine |
US20090264477A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc., An Indiana Corporation | Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
US20100015049A1 (en) * | 2008-07-16 | 2010-01-21 | Warsaw Orthopedic, Inc. | Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
US9492375B2 (en) | 2008-07-23 | 2016-11-15 | Warsaw Orthopedic, Inc. | Foam carrier for bone grafting |
JP2010155820A (ja) * | 2008-10-10 | 2010-07-15 | Hayashikane Sangyo Kk | 皮膚改善剤、血管改善剤、並びにこれらを含む医薬組成物、食品、飼料及び化粧品 |
US20100098746A1 (en) * | 2008-10-20 | 2010-04-22 | Warsaw Orthopedic, Inc. | Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
US9161903B2 (en) * | 2008-10-31 | 2015-10-20 | Warsaw Orthopedic, Inc. | Flowable composition that hardens on delivery to a target tissue site beneath the skin |
US8980317B2 (en) | 2008-12-23 | 2015-03-17 | Warsaw Orthopedic, Inc. | Methods and compositions for treating infections comprising a local anesthetic |
US20100226959A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Matrix that prolongs growth factor release |
US20100228097A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Methods and compositions to diagnose pain |
US20100239632A1 (en) | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
US8617583B2 (en) | 2009-07-17 | 2013-12-31 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis |
US8653029B2 (en) | 2009-07-30 | 2014-02-18 | Warsaw Orthopedic, Inc. | Flowable paste and putty bone void filler |
US8231891B2 (en) | 2009-07-31 | 2012-07-31 | Warsaw Orthopedic, Inc. | Implantable drug depot for weight control |
US20110097375A1 (en) | 2009-10-26 | 2011-04-28 | Warsaw Orthopedic, Inc. | Formulation for preventing or reducing bleeding at a surgical site |
US20110097380A1 (en) * | 2009-10-28 | 2011-04-28 | Warsaw Orthopedic, Inc. | Clonidine formulations having antimicrobial properties |
US9504698B2 (en) * | 2009-10-29 | 2016-11-29 | Warsaw Orthopedic, Inc. | Flowable composition that sets to a substantially non-flowable state |
US8597192B2 (en) | 2009-10-30 | 2013-12-03 | Warsaw Orthopedic, Inc. | Ultrasonic devices and methods to diagnose pain generators |
US8758791B2 (en) * | 2010-01-26 | 2014-06-24 | Warsaw Orthopedic, Inc. | Highly compression resistant matrix with porous skeleton |
US8475824B2 (en) * | 2010-01-26 | 2013-07-02 | Warsaw Orthopedic, Inc. | Resorbable matrix having elongated particles |
US9050274B2 (en) * | 2010-01-28 | 2015-06-09 | Warsaw Orthopedic, Inc. | Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents |
US9486500B2 (en) | 2010-01-28 | 2016-11-08 | Warsaw Orthopedic, Inc. | Osteoimplant and methods for making |
US9125902B2 (en) * | 2010-01-28 | 2015-09-08 | Warsaw Orthopedic, Inc. | Methods for treating an intervertebral disc using local analgesics |
US8246571B2 (en) | 2010-08-24 | 2012-08-21 | Warsaw Orthopedic, Inc. | Drug storage and delivery device having a retaining member |
JP6083085B2 (ja) * | 2010-09-08 | 2017-02-22 | 国立大学法人九州工業大学 | アンジオテンシン変換酵素阻害剤およびその用途 |
US9414930B2 (en) | 2010-10-26 | 2016-08-16 | Kyphon SÀRL | Activatable devices containing a chemonucleolysis agent |
US8740982B2 (en) | 2010-10-26 | 2014-06-03 | Kyphon Sarl | Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis |
US8404268B2 (en) | 2010-10-26 | 2013-03-26 | Kyphon Sarl | Locally targeted anti-fibrotic agents and methods of use |
WO2012075447A2 (en) | 2010-12-03 | 2012-06-07 | Warsaw Orthopedic, Inc. | Compositions and methods for delivering clonidine and bupivacaine to a target tissue site |
WO2012075451A2 (en) | 2010-12-03 | 2012-06-07 | Warsaw Orthopedic, Inc. | Clonidine and gaba compounds in a biodegradable polymer carrier |
US9060978B2 (en) | 2011-01-24 | 2015-06-23 | Warsaw Orthopedic, Inc. | Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist |
US9717779B2 (en) | 2011-01-31 | 2017-08-01 | Warsaw Orthopedic, Inc. | Implantable matrix having optimum ligand concentrations |
EP2683393B1 (en) * | 2011-02-11 | 2018-04-11 | The Regents of The University of Michigan | Tripeptide compositions and their use for treatment of diabetes |
US9592243B2 (en) | 2011-04-25 | 2017-03-14 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an anabolic agent for treatment of an injury |
US9511077B2 (en) | 2011-04-25 | 2016-12-06 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an anabolic agent for wound healing |
US9205241B2 (en) | 2011-07-12 | 2015-12-08 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an adhesive material |
US9132194B2 (en) | 2011-07-12 | 2015-09-15 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an adhesive sheet containing a drug depot |
US9511018B2 (en) | 2012-04-05 | 2016-12-06 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable matrix |
US8735504B2 (en) | 2012-05-02 | 2014-05-27 | Warsaw Orthopedic, Inc. | Methods for preparing polymers having low residual monomer content |
US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
US10080877B2 (en) | 2014-07-25 | 2018-09-25 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a drug cartridge |
US9775978B2 (en) | 2014-07-25 | 2017-10-03 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
US10076650B2 (en) | 2015-11-23 | 2018-09-18 | Warsaw Orthopedic, Inc. | Enhanced stylet for drug depot injector |
KR101706296B1 (ko) | 2015-12-21 | 2017-02-13 | 주식회사 브레인온 | 기억력, 학습력, 인지력 향상용 조성물 |
AU2016376059B2 (en) * | 2015-12-21 | 2019-02-14 | Brainon Inc. | Composition for improving memory, learning ability and cognition |
USD802756S1 (en) | 2016-06-23 | 2017-11-14 | Warsaw Orthopedic, Inc. | Drug pellet cartridge |
KR102504364B1 (ko) * | 2016-10-04 | 2023-02-28 | 주식회사 엘지생활건강 | 류신 유도체, 이를 포함하는 조성물 및 이의 용도 |
CN107890116B (zh) * | 2016-10-04 | 2023-01-10 | 株式会社Lg生活健康 | 亮氨酸衍生物、包含其的组合物及其用途 |
US10434261B2 (en) | 2016-11-08 | 2019-10-08 | Warsaw Orthopedic, Inc. | Drug pellet delivery system and method |
KR102007079B1 (ko) * | 2017-03-24 | 2019-10-02 | (주)셀아이콘랩 | 펩타이드를 활용한 피부의 노화 억제용 조성물 및 세포노화 억제와 주름개선을 위한 화장품 조성물 |
GB201711360D0 (en) * | 2017-07-14 | 2017-08-30 | Raft Entpr Ltd | Tissue scaffold |
JP2019112401A (ja) * | 2017-12-22 | 2019-07-11 | 株式会社バイタルリソース応用研究所 | アンジオテンシン変換酵素阻害化合物 |
CN108261539A (zh) * | 2018-02-27 | 2018-07-10 | 南京圣诺生物科技实业有限公司 | 一种用于抗血栓的组合物、其制备方法及用途 |
CN108588155A (zh) * | 2018-04-18 | 2018-09-28 | 珀莱雅化妆品股份有限公司 | 一种酶解猪动脉血管制备弹力蛋白肽的方法 |
WO2021234483A1 (en) * | 2020-05-22 | 2021-11-25 | Sunshine Biopharma Inc. | Inhibitors of coronavirus protease |
FR3116273B1 (fr) * | 2020-11-17 | 2023-10-27 | Sederma Sa | Tétrapeptides, compositions les comprenant et leur utilisation cosmétique |
KR20230047692A (ko) * | 2021-10-01 | 2023-04-10 | (주)케어젠 | 탈모 방지 또는 발모 촉진 활성을 갖는 펩타이드와 이의 용도 |
KR102484277B1 (ko) * | 2021-11-22 | 2023-01-04 | 대한켐텍 주식회사 | 피부 미용 개선용 원료 조성물의 제조방법 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7713618A (nl) * | 1976-12-11 | 1978-06-13 | Bayer Ag | Werkwijze voor de bereiding van een cosmetisch preparaat. |
DE2705670C3 (de) * | 1977-02-11 | 1983-11-17 | Fa. Carl Freudenberg, 6940 Weinheim | Verfahren zur Herstellung von wasserlöslichen Elastin-Hydrolysaten |
US4591501A (en) * | 1981-04-13 | 1986-05-27 | Seton Company | Cosmetic and pharmaceutical sheet material containing polypeptides |
US4474763A (en) * | 1982-07-07 | 1984-10-02 | Lubowe Irwin I | Skin preparation |
US4659740A (en) * | 1985-02-14 | 1987-04-21 | Polydex Pharmaceuticals Ltd. | Cosmetic preparations comprising novel elastin derivatives |
US5223420A (en) * | 1985-03-01 | 1993-06-29 | Institut National De La Sante Et De La Recherche Medicale | Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials and artificial supports |
US5017691A (en) * | 1986-07-03 | 1991-05-21 | Schering Corporation | Mammalian interleukin-4 |
JP2549118B2 (ja) * | 1987-05-30 | 1996-10-30 | 三省製薬株式会社 | 乳化組成物 |
US5079003A (en) * | 1990-03-14 | 1992-01-07 | Adelia Scaffidi | Skin lotions and creams |
US5523291A (en) * | 1993-09-07 | 1996-06-04 | Datascope Investment Corp. | Injectable compositions for soft tissue augmentation |
FR2721031B1 (fr) * | 1994-06-09 | 1996-07-26 | Centre Nat Rech Scient | Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic. |
JP2863898B2 (ja) * | 1995-02-21 | 1999-03-03 | 末綱 陽子 | 新規なペプチドおよび免疫賦活剤 |
US5945409A (en) * | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
JP2012225594A (ja) * | 2011-04-21 | 2012-11-15 | Panasonic Corp | 製氷装置 |
-
1998
- 1998-03-13 US US09/039,308 patent/US6069129A/en not_active Expired - Fee Related
-
1999
- 1999-03-12 WO PCT/US1999/005496 patent/WO1999045941A1/en active IP Right Grant
- 1999-03-12 EA EA200000933A patent/EA003857B1/ru unknown
- 1999-03-12 OA OA1200000249A patent/OA11531A/en unknown
- 1999-03-12 DE DE69938174T patent/DE69938174T2/de not_active Expired - Fee Related
- 1999-03-12 CN CNB998059390A patent/CN100364606C/zh not_active Expired - Fee Related
- 1999-03-12 JP JP2000535355A patent/JP2002506041A/ja active Pending
- 1999-03-12 NZ NZ506898A patent/NZ506898A/en unknown
- 1999-03-12 KR KR1020007010112A patent/KR100612535B1/ko not_active IP Right Cessation
- 1999-03-12 AP APAP/P/2000/001905A patent/AP2000001905A0/en unknown
- 1999-03-12 BR BR9908749-9A patent/BR9908749A/pt not_active Application Discontinuation
- 1999-03-12 EP EP99912486A patent/EP1064010B1/en not_active Expired - Lifetime
- 1999-03-12 ID IDW20002053A patent/ID28270A/id unknown
- 1999-03-12 AT AT99912486T patent/ATE386536T1/de not_active IP Right Cessation
- 1999-03-12 IL IL13845399A patent/IL138453A0/xx active IP Right Revival
- 1999-03-12 CA CA002322839A patent/CA2322839A1/en not_active Abandoned
- 1999-03-12 AU AU30854/99A patent/AU765379B2/en not_active Ceased
-
2000
- 2000-05-30 US US09/584,001 patent/US6506731B1/en not_active Expired - Fee Related
- 2000-09-12 NO NO20004540A patent/NO325371B1/no not_active IP Right Cessation
- 2000-09-13 IL IL138453A patent/IL138453A/en not_active IP Right Cessation
-
2001
- 2001-10-11 HK HK01107123A patent/HK1036225A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2002506041A (ja) | 2002-02-26 |
DE69938174D1 (de) | 2008-04-03 |
NO20004540L (no) | 2000-11-09 |
OA11531A (en) | 2004-05-06 |
EP1064010A1 (en) | 2001-01-03 |
AP2000001905A0 (en) | 2000-09-30 |
NO20004540D0 (no) | 2000-09-12 |
US6069129A (en) | 2000-05-30 |
EP1064010A4 (en) | 2004-10-06 |
EA003857B1 (ru) | 2003-10-30 |
ATE386536T1 (de) | 2008-03-15 |
CA2322839A1 (en) | 1999-09-16 |
CN1300220A (zh) | 2001-06-20 |
IL138453A (en) | 2007-07-24 |
KR20010041827A (ko) | 2001-05-25 |
CN100364606C (zh) | 2008-01-30 |
AU765379B2 (en) | 2003-09-18 |
AU3085499A (en) | 1999-09-27 |
HK1036225A1 (en) | 2001-12-28 |
EP1064010B1 (en) | 2008-02-20 |
NZ506898A (en) | 2003-05-30 |
KR100612535B1 (ko) | 2006-08-11 |
DE69938174T2 (de) | 2009-01-08 |
US6506731B1 (en) | 2003-01-14 |
ID28270A (id) | 2001-05-10 |
IL138453A0 (en) | 2001-10-31 |
WO1999045941A1 (en) | 1999-09-16 |
NO325371B1 (no) | 2008-04-14 |
BR9908749A (pt) | 2001-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200000933A1 (ru) | Пептидные композиции и препараты и их применение | |
FI895382A0 (fi) | Uretan-skyddade aminosyra-n -karboxianhydrider. | |
NL300106I2 (nl) | N-terminaal chemisch gemodificeerde eiwitpreparaten en werkwijzen. | |
FR2767833B1 (fr) | Polypeptide isole de l'epiderme et son utilisation | |
DE69942035D1 (de) | Menschliches parathyroidhormon, modifikationen, herstellung und verwendung | |
DE69922822D1 (de) | Rekombinante haarbehandlungsmittel | |
EA200100337A1 (ru) | Стабильные жидкие составы ботулинического токсина | |
DE69435075D1 (de) | , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
PT792287E (pt) | Analogos peptidicos da proteina basica da mielina humana | |
EA199901013A1 (ru) | Гели пролонгированного действия | |
ATE278708T1 (de) | Conotoxin peptid pviia | |
ATE396205T1 (de) | Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe | |
BR0211186A (pt) | peptìdeos e uso dos mesmos no escurecimento da pele | |
MXPA02000465A (es) | Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6. | |
GB0016189D0 (en) | Cosmetic composition | |
ATE177843T1 (de) | Peptomere mit erhöhter immunogenizität | |
AU2003292326A1 (en) | Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser | |
DE69935414D1 (en) | Humanes btrcp protein | |
LT2002051A (en) | Mimetic peptides for epitope of apoliprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same | |
HUP9702500A2 (hu) | Elhízás elleni proteinek | |
WO1996003122A3 (en) | Use of gabapentin in the treatment of anxiety and panic | |
RU99116976A (ru) | Миелопептиды и их терапевтическое использование | |
BR0308040A (pt) | Composições farmacêuticas e cosméticas compreendendo plgf-1 | |
ATE305041T1 (de) | Kompositionen und verwendungen von cgi-69 | |
DK1043974T3 (da) | Liposomer indeholdende flergrenede peptidkonstruktioner til anvendelse mod human immundefektvirus |